Extendicare Inc. (EXETF)
OTCMKTS · Delayed Price · Currency is USD
9.81
+0.03 (0.31%)
Aug 13, 2025, 12:14 PM EDT
Extendicare Market Cap
Extendicare has a market cap or net worth of $819.45 million as of August 14, 2025. Its market cap has increased by 77.11% in one year.
Market Cap
819.45M
Enterprise Value
973.07M
Revenue
1.11B
Ranking
n/a
PE Ratio
13.44
Stock Price
$9.81
Market Cap Chart
Since May 15, 1997, Extendicare's market cap has decreased from 973.52M to 819.45M, a decrease of -15.83%. That is a compound annual growth rate of -0.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 819.45M | 32.89% |
| Dec 31, 2024 | 616.65M | 33.95% |
| Dec 29, 2023 | 460.35M | 11.06% |
| Dec 30, 2022 | 414.49M | -19.77% |
| Dec 31, 2021 | 516.64M | 10.73% |
| Dec 31, 2020 | 466.60M | -19.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 625.65M |
| Glass House Brands | 497.52M |
| Northwest Biotherapeutics | 367.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 322.85M |